Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America
People living with schizophrenia or BP-I, caregivers, and prescribers in the United States and Canada generally had favorable views of LAIs administered once every 2 months. Quantitative follow-up research that extends these findings is warranted.
Authors
- Murat Yıldırım (ORCID: https://orcid.org/0000-0003-1089-1380)
- Stephanie Loomer (ORCID: https://orcid.org/0000-0002-0859-7994)
- Kristine Harrsen
- Xavier Guillaume (ORCID: https://orcid.org/0009-0006-1882-3349)
- Arun Micheelsen (ORCID: https://orcid.org/0000-0001-8243-4184)
- Pedro Such (ORCID: https://orcid.org/0000-0003-1905-1142)
- Dawn Bates
- Clodagh Beckham (ORCID: https://orcid.org/0009-0003-2351-2519)
- Soma S. Nag
- Roger S. McIntyre
Institutions
- Lundbeck (Denmark) (DK)
- Oracle (United States) (US)
- University of Toronto (CA)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1080/03007995.2025.2585558
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00